Advertisement

Lung Cancer

  • R. L. Comis
Part of the UICC International Union Against Cancer book series (UICCI)

Abstract

In the United States alone there will be approximately 140 000 cases of lung cancer during 1987. Functionally, these diseases are divided into tumors of the non-small cell (NSCL) and small cell (SCLC) varieties. The former category includes squamous cell adenocarcinoma and large cell anaplastic tumors and the latter includes small cell anaplastic carcinoma, all defined by light microscopy. This functional classification is based upon each category’s distinctive clinical biology, i.e., (a) the potential for surgical curability of NSCL; (b) the propensity of SCLC to widespread dissemination; and (c) the relative responsiveness or unresponsiveness of SCLC and NSCL to existing cytotoxic modalities.

Keywords

Small Cell Lung Cancer Small Cell Carcinoma Limited Disease International Staging System Human Small Cell Lung Cancer 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Carney DN, Broder L, Edelstein M et al. (1983) Experimental studies of the biology of human small cell lung cancer. Cancer Treat Rep 67: 27PubMedGoogle Scholar
  2. 2.
    Mountain CF (1986) A new international staging system for lung cancer. Chest 89: 225SGoogle Scholar
  3. 3.
    Greco FA (1986) Rationale for chemotherapy for patients with advanced non-small cell lung cancer. Semin Oncol 13: 92PubMedGoogle Scholar
  4. 4.
    Comis RL (1987) Chemotherapy of small cell lung cancer. In: DeVita VT, Hellman S, Rosenberg SA (eds) Principles and practice of oncology update, vol 1. Lippincott, Philadelphia, p 7Google Scholar
  5. 5.
    Perry MC, Eaton WL, Propert KJ et al. (1987) Chemotherapy with or without radiation therapy in limited small cell carcinoma of the lung. N Engl J Med 316: 912PubMedCrossRefGoogle Scholar
  6. 6.
    Einhorn L, Greco FA, Cohen H, Birch R (1987) Late consolidation with cisplatin plus VP-16 (PVP16) following induction chemotherapy with cyclophosphamide, adriamycin and vincristine (CAV) in limited small cell lung cancer (SCLC): a Southeastern Cancer Study Group ( SECSG) random prospective study. Proc Am Soc Clin Oncol 6: 166Google Scholar
  7. 7.
    Feld R, Evans WK, Coy P et al. (1987) Canadian multicenter randomized trial comparing sequential and alternating administration of two noncross-resistant chemotherapy combinations in patients with limited small-cell carcinoma of the lung. J Clin Oncol 5 (9): 1401PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • R. L. Comis

There are no affiliations available

Personalised recommendations